3. Oral insulin film from MonoSol and Midatech

Back in 2008, MonoSol ($MSRX) and Midatech teamed up to develop PharmFilm, a through-the-cheek nanoparticle-delivery platform they eventually patented in 2010. Now, the duo is developing an insulin-delivery application for the transbuccal tech. PharmFilm is a quick-dissolve mucoadhesive film, sticking to the inside of the cheek and delivering APIs. Loading the film with insulin presents a lucrative opportunity, the companies figure, and the diabetes-treating formulation got some positive results in Phase I. The bioavailability and pharmacokinetics were all up to snuff, and the stamp-sized strips worked faster than subcutaneous insulin, the companies said. MonoSol and Midatech haven't disclosed a planned timeline for the tech, but they've got more human trials on the horizon.

3. Oral insulin film from MonoSol and Midatech
Read more on

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.